Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Paolo Antonio Ascierto
Based on 160 articles published since 2008
||||
Expertise Level
The expertise of Paolo Antonio Ascierto ranks in the
  • Top 0.012%
  • ... of 101,532 published authors worldwide on Melanoma
  • ... from 2008 through 2018
  • ... based on contributions to 160 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Ascierto, Paolo   ·   Ascierto, P A   ·   Ascierto, P   ·   Ascierto, Paolo Antonio   ·   Ascierto, Paolo A
Work Locations
Details
Most likely:    National Cancer Institute Naples      
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
  • New York University Perlmutter Cancer Center, New York, NY · Bristol-Myers Squibb, Princeton, NJ · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy · Pubmed 29446288
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. Electronic address: · Department of Otorhinolaryngology, University of Brescia, Italy. · Department of Pathology and Cytopathology, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Department of Radiology, University of Brescia, Italy. · Particle Therapy Cancer Research Institute, CNAO Foundation, Milan, Italy. · Evaluative Epidemiology Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan, Italy. · First Department of Medicine, Laiko General Hospital, Athens, Greece. · Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Pubmed 28325255
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Napoli, Italia. · CROM, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Napoli, Italia. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italia. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Roma, Italia. · IRCCS Istituto Nazionale Tumori "Regina Elena", Roma, Italy. · Pubmed 28118616
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, Siena, Italy. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, Milan, Italy. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyons Cancer Research Center, Lyon 1 University, Pierre Bénite, France. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russian Federation. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Medicine, University Health Network/Princess Margaret Hospital, Toronto, ON, Canada. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Medical Oncology, Institute for Cancer Research, IRCCS San Martino, Largo Rosanna Benzi, Genova, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 28284557
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University of Campania "Luigi Vanvitelli", Naples, Italy. · Peptipharma, Viale Città D'Europa 679, 00144, Rome, Italy. · Institute of Genetics and Biophysics, National Research Council, Naples, Italy. · IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy. · IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University 'Parthenope', Via Acton 38, 80133, Naples, Italy. · Pubmed 29216889
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U, National Cancer Institute "G. Pascale", Naples, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · PhD Program in Drug Discovery and Development, University of Salerno, Fisciano, SA, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Pubmed 29202855
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
  • Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Struttura Complessa di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Genomica Funzionale, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Pharmacy, University of Naples "Federico II", 80131, Naples, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100, Sassari, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28231855
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Pubmed 28167454
  • Pathology Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Psychiatry, Pathology Unit, University of Naples SUN, Naples, Italy. · Pubmed 28067428
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • INSERM (National Institute of Health and Medical Research), Paris, France. · Institute of Pathology, University of Bern, Bern, Switzerland. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Laboratory of Immunology, Hopital Européen Georges Pompidou, Paris, France. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · AbbVie Medical Corporation, Redwood City, CA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 29058595
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Department of Dermatology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Department of Oncology, Lausanne University Hospital, Champ de l'Air, Rue du Bugnon 21, 1011, Lausanne, Switzerland. · Ludwig Centre and Swiss Institute of Bioinformatics, Génopode Building, 1015, Lausanne, Switzerland. · Istituto Nazionale Tumori, Fondazione 'G. Pascale', Via Mariano Semmola, 52, 80131, Naples, Italy. · Clinical Development, Amgen Europe GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. · Pubmed 27372293
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • a Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy , Istituto Nazionale Tumori Fondazione G. Pascale , Napoli , Italy. · b Sidra Medical and Research Centre , Doha , Qatar. · Pubmed 26642234
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Melanoma Institute Australia, The University of Sydney, and Mater Hospital, Sydney, Australia · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, Greenslopes, Australia. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Gustave-Roussy, Paris, France. · University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · BC Cancer Agency, University of British Columbia, Vancouver, Canada. · Adelphi Values, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Duke Clinical Research Institute, Durham, NC, USA. · Pubmed 27405322
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • Laboratory of Integrative Cancer Immunology, INSERM UMRS1138 Cordeliers Research Center, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · University Paris Descartes, 45 Rue Saints Pères, 75006, Paris, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Institute of Pathology, University of Bern, Bern, Switzerland. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Center, Doha, Qatar. · IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale",Scentific Directorate, Naples, Italy. · Laboratory of Integrative Cancer Immunology, INSERM UMRS1138, Cordeliers Research Center, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Centre de Recherche des Cordeliers, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Immunomonitoring Platform, Laboratory of Immunology, Georges Pompidou European Hospital, 20-40 Rue Leblanc, 75015, Paris, France. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Pubmed 27650038
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome 00161, Italy; · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Department of Genetics, Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10029; · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro 88100, Italy; · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600 Locarno, Switzerland. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Pubmed 27503895
  • Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. Electronic address: · European Institute of Oncology (IEO), Milano, Italy. · Department of Dermatology and Plastic Surgery, University of Rome ''La Sapienza'', Roma, Italy. · Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy. · Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. · Department of Surgery and Advanced Cancer Therapies, Morgagni-Pierantoni Hospital, Forlì, Italy. · Plastic Surgery Unit, Tuscan Tumor Institute (ITT), Santa Maria Annunziata Hospital, Firenze, Italy. · National Cancer Institute, Fondazione Pascale, Naples, Italy. · Medical Oncology Unit, Giovanni Paolo II Cancer Institute, Bari, Italy. · Plastic Surgery Unit, San Gallicano Dermatology Institute, Roma, Italy. · Clinical Trials and Biostatistics Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. · Pubmed 27424789
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany; Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany. · Singapore Immunology Network, Agency for Science, Technology and Research, Singapore. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27400322
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy, Istituto nazionale Tumori Fondazione "G Pascale", Napoli, 80131, Italy. Electronic address: · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospital, Sydney, Australia. · Pubmed 27324281
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, United Kingdom. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27169993
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Immunology, University of Tübingen, Tübingen, Germany. · Pubmed 26787752
  • Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Electronic address: · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy. · Section of Oncology and Immunology, Department of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy. · Melanoma and Soft Tissue Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Medical Genetics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Dermatology, University of Florence, Florence, Italy. · Unit of Medical Genetics, Department of Biomedical Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Plastic Surgery Unit, Regional Melanoma Referral Center, Santa Maria Annunziata Hospital, Florence, Italy. · Division of Dermatoncological Surgery, European Institute of Oncology, Milan, Italy. · Medical Oncology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Dermatology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy. · Dermatoncological Surgery Unit, Presidio Sanitario Gradenigo, Turin, Italy. · Anatomopathology Unit, Università dell'Insubria, Ospedale di Circolo, Varese, Italy. · Dermatology Unit, Ospedale di Circolo, Varese, Italy. · Cancer Genetics Unit, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Melanoma, National Cancer Institute Pascale Foundation, Naples, Italy. · Dermatology Unit, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-Istituto Nazionale dei Tumori (IST) Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Pubmed 26775776
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. · Istituto Nazionale Tumori, Napoli, Italy. · Dipartimento di Chirurgia, Microchirurgia e Scienze Mediche, Università di Sassari, Sassari, Italy. · Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. Electronic address: · Pubmed 27265006
2015
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Napoli, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Pubmed 26137543
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples, Italy. · Dipartimento di Chirurgia "P. Valdoni", Sapienza Università di Roma, Rome, Italy. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italy. · Takis S.r.l., Rome, Italy. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Azienda Ospedaliera S. Andrea, Rome, Italy. · Pubmed 26208478
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Oncology and Medicine, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, 3970 Reservoir Rd NW, Washington, DC, 20057, USA. · Pubmed 26141621
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori - Fondazione 'G. Pascale', Via Mariano Semmola, 80131, Naples, Italy, · Pubmed 25549844
  • Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States; Sidra Medical and Research Center, Doha, Qatar. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Institute of Biosciences and BioResources-IBB, CNR, Naples I-8013, Italy. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States. · Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples I-80131, Italy. · Pubmed 25444926
  • Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry, Biocenter, University of Wuerzburg, Wuerzburg 97074, Germany; Genelux Corporation, San Diego Science Center, San Diego 92109, USA. · Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Center of Excellence for Biomedical Research (CEBR), University of Genoa, Italy. · Department of Biology, Northern Michigan University, Marquette, MI, USA. · Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Institute of Infectious and Tropical Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via G. Semmola, Naples, Italy. · Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Pubmed 25174651
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy. · Pubmed 25015684
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24577788
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · UOC Biologia cellulare, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOC Epidemiologia Clinica, IRCCS A.O.U. San Martino-IST, Genova, Italy. · Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · Unità di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · UOC Oncologia Medica 2, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. Electronic address: · Pubmed 24801647
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · "Paolo Giaccone" Polyclinic University Hospital, Palermo, Italy. · Divisione Melanoma e Sarcomi Muscolo-Cutanei, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Unità di Ricerca Traslazionale sul Melanoma, Divisione di Oncologia Medica del Melanoma, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy. · San Martino Hospital, National Institute for Cancer Research, Genoa, Italy. · University Hospital Pisa, "Gathered Hospitals of Santa Chiara", Pisa, Italy. · Department of Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 24100024
2013
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale," Naples, Italy. · Pubmed 22874771
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy. · Pubmed 23460532
  • Istituto Nazionale Tumori, Fondazione "G, Pascale", Naples, Italy. · Pubmed 23731854
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 22551296
2011
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 21439082
2010
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • aDepartment of Medical Oncology, Royal North Shore Hospital bDepartment of Medical Oncology Melanoma Institute Australia cDepartment of Medical Oncology, The University of Sydney, Sydney, New South Wales, Australia dDepartment of Medical Oncology, Istituto Nazionale Tumori 'Fondazione Pascale', Naples, Campania, Italy. · Pubmed 28230715
2015
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Unit of Melanoma, Immunotherapy and Innovative Therapies, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24114495
  • Pathology Unit, Istituto Nazionale Tumori Fondazione, "G. Pascale", via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24993904
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • National Cancer Institute-Fondazione Pascale, Naples, Italy. · Pubmed 23036080
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Department Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 23317446
2012
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy. · Pubmed 22433222
  • Department of Surgery, National Cancer Institute, Via Mariano Semmola, Naples, Italy. · Pubmed 22800396
  • Pathology Unit, Istituto Nazionale Tumori Fondazione G, Pascale, via Mariano Semmola, 80131, Naples, Italy. · Pubmed 22583695
2011
  • Division of Cardiology, National Cancer Institute, Sen. Pascale Foundation, via Mariano Semmola, 80131 Naples, Italy. · Pubmed 21705351
Probable:    Harvard University   Contact    
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Probable:    National Institutes of Health      
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 160 total) written by Paolo Antonio Ascierto about Melanoma:

  • Emerging Strategies in Systemic Therapy for the Treatment of Melanoma. 2018
  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. 2018
  • Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. 2018
  • Adjuvant Therapy in Resected Melanoma. 2018
  • Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III. 2018
  • Checkpoint inhibitors in melanoma and early phase development in solid tumors: what's the future? 2017
  • Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. 2017
  • MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors. 2017
  • Mucosal melanoma of the head and neck. 2017
  • MicroRNAs in melanoma development and resistance to target therapy. 2017
Show List of Full Article Records
Google Searches

Learn more about Paolo Antonio Ascierto using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Cancer Institute Naples
Harvard University
National Institutes of Health
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Cancer Institute Naples
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
  • New York University Perlmutter Cancer Center, New York, NY · Bristol-Myers Squibb, Princeton, NJ · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy · Pubmed 29446288
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. Electronic address: · Department of Otorhinolaryngology, University of Brescia, Italy. · Department of Pathology and Cytopathology, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Department of Radiology, University of Brescia, Italy. · Particle Therapy Cancer Research Institute, CNAO Foundation, Milan, Italy. · Evaluative Epidemiology Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan, Italy. · First Department of Medicine, Laiko General Hospital, Athens, Greece. · Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Pubmed 28325255
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Napoli, Italia. · CROM, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Napoli, Italia. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italia. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Roma, Italia. · IRCCS Istituto Nazionale Tumori "Regina Elena", Roma, Italy. · Pubmed 28118616
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, Siena, Italy. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, Milan, Italy. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyons Cancer Research Center, Lyon 1 University, Pierre Bénite, France. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russian Federation. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Medicine, University Health Network/Princess Margaret Hospital, Toronto, ON, Canada. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Medical Oncology, Institute for Cancer Research, IRCCS San Martino, Largo Rosanna Benzi, Genova, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 28284557
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University of Campania "Luigi Vanvitelli", Naples, Italy. · Peptipharma, Viale Città D'Europa 679, 00144, Rome, Italy. · Institute of Genetics and Biophysics, National Research Council, Naples, Italy. · IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy. · IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University 'Parthenope', Via Acton 38, 80133, Naples, Italy. · Pubmed 29216889
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U, National Cancer Institute "G. Pascale", Naples, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · PhD Program in Drug Discovery and Development, University of Salerno, Fisciano, SA, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Pubmed 29202855
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
  • Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Struttura Complessa di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Genomica Funzionale, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Pharmacy, University of Naples "Federico II", 80131, Naples, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100, Sassari, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28231855
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Pubmed 28167454
  • Pathology Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Psychiatry, Pathology Unit, University of Naples SUN, Naples, Italy. · Pubmed 28067428
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • INSERM (National Institute of Health and Medical Research), Paris, France. · Institute of Pathology, University of Bern, Bern, Switzerland. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Laboratory of Immunology, Hopital Européen Georges Pompidou, Paris, France. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · AbbVie Medical Corporation, Redwood City, CA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 29058595
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Department of Dermatology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Department of Oncology, Lausanne University Hospital, Champ de l'Air, Rue du Bugnon 21, 1011, Lausanne, Switzerland. · Ludwig Centre and Swiss Institute of Bioinformatics, Génopode Building, 1015, Lausanne, Switzerland. · Istituto Nazionale Tumori, Fondazione 'G. Pascale', Via Mariano Semmola, 52, 80131, Naples, Italy. · Clinical Development, Amgen Europe GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. · Pubmed 27372293
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • a Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy , Istituto Nazionale Tumori Fondazione G. Pascale , Napoli , Italy. · b Sidra Medical and Research Centre , Doha , Qatar. · Pubmed 26642234
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Melanoma Institute Australia, The University of Sydney, and Mater Hospital, Sydney, Australia · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, Greenslopes, Australia. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Gustave-Roussy, Paris, France. · University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · BC Cancer Agency, University of British Columbia, Vancouver, Canada. · Adelphi Values, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Duke Clinical Research Institute, Durham, NC, USA. · Pubmed 27405322
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • Laboratory of Integrative Cancer Immunology, INSERM UMRS1138 Cordeliers Research Center, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · University Paris Descartes, 45 Rue Saints Pères, 75006, Paris, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Institute of Pathology, University of Bern, Bern, Switzerland. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Center, Doha, Qatar. · IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale",Scentific Directorate, Naples, Italy. · Laboratory of Integrative Cancer Immunology, INSERM UMRS1138, Cordeliers Research Center, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Centre de Recherche des Cordeliers, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Immunomonitoring Platform, Laboratory of Immunology, Georges Pompidou European Hospital, 20-40 Rue Leblanc, 75015, Paris, France. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Pubmed 27650038
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome 00161, Italy; · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Department of Genetics, Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10029; · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro 88100, Italy; · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600 Locarno, Switzerland. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Pubmed 27503895
  • Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. Electronic address: · European Institute of Oncology (IEO), Milano, Italy. · Department of Dermatology and Plastic Surgery, University of Rome ''La Sapienza'', Roma, Italy. · Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy. · Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. · Department of Surgery and Advanced Cancer Therapies, Morgagni-Pierantoni Hospital, Forlì, Italy. · Plastic Surgery Unit, Tuscan Tumor Institute (ITT), Santa Maria Annunziata Hospital, Firenze, Italy. · National Cancer Institute, Fondazione Pascale, Naples, Italy. · Medical Oncology Unit, Giovanni Paolo II Cancer Institute, Bari, Italy. · Plastic Surgery Unit, San Gallicano Dermatology Institute, Roma, Italy. · Clinical Trials and Biostatistics Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. · Pubmed 27424789
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany; Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany. · Singapore Immunology Network, Agency for Science, Technology and Research, Singapore. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27400322
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy, Istituto nazionale Tumori Fondazione "G Pascale", Napoli, 80131, Italy. Electronic address: · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospital, Sydney, Australia. · Pubmed 27324281
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, United Kingdom. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27169993
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Immunology, University of Tübingen, Tübingen, Germany. · Pubmed 26787752
  • Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Electronic address: · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy. · Section of Oncology and Immunology, Department of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy. · Melanoma and Soft Tissue Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Medical Genetics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Dermatology, University of Florence, Florence, Italy. · Unit of Medical Genetics, Department of Biomedical Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Plastic Surgery Unit, Regional Melanoma Referral Center, Santa Maria Annunziata Hospital, Florence, Italy. · Division of Dermatoncological Surgery, European Institute of Oncology, Milan, Italy. · Medical Oncology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Dermatology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy. · Dermatoncological Surgery Unit, Presidio Sanitario Gradenigo, Turin, Italy. · Anatomopathology Unit, Università dell'Insubria, Ospedale di Circolo, Varese, Italy. · Dermatology Unit, Ospedale di Circolo, Varese, Italy. · Cancer Genetics Unit, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Melanoma, National Cancer Institute Pascale Foundation, Naples, Italy. · Dermatology Unit, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-Istituto Nazionale dei Tumori (IST) Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Pubmed 26775776
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. · Istituto Nazionale Tumori, Napoli, Italy. · Dipartimento di Chirurgia, Microchirurgia e Scienze Mediche, Università di Sassari, Sassari, Italy. · Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. Electronic address: · Pubmed 27265006
2015
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Napoli, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Pubmed 26137543
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples, Italy. · Dipartimento di Chirurgia "P. Valdoni", Sapienza Università di Roma, Rome, Italy. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italy. · Takis S.r.l., Rome, Italy. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Azienda Ospedaliera S. Andrea, Rome, Italy. · Pubmed 26208478
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Oncology and Medicine, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, 3970 Reservoir Rd NW, Washington, DC, 20057, USA. · Pubmed 26141621
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori - Fondazione 'G. Pascale', Via Mariano Semmola, 80131, Naples, Italy, · Pubmed 25549844
  • Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States; Sidra Medical and Research Center, Doha, Qatar. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Institute of Biosciences and BioResources-IBB, CNR, Naples I-8013, Italy. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States. · Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples I-80131, Italy. · Pubmed 25444926
  • Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry, Biocenter, University of Wuerzburg, Wuerzburg 97074, Germany; Genelux Corporation, San Diego Science Center, San Diego 92109, USA. · Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Center of Excellence for Biomedical Research (CEBR), University of Genoa, Italy. · Department of Biology, Northern Michigan University, Marquette, MI, USA. · Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Institute of Infectious and Tropical Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via G. Semmola, Naples, Italy. · Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Pubmed 25174651
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy. · Pubmed 25015684
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24577788
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · UOC Biologia cellulare, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOC Epidemiologia Clinica, IRCCS A.O.U. San Martino-IST, Genova, Italy. · Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · Unità di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · UOC Oncologia Medica 2, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. Electronic address: · Pubmed 24801647
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · "Paolo Giaccone" Polyclinic University Hospital, Palermo, Italy. · Divisione Melanoma e Sarcomi Muscolo-Cutanei, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Unità di Ricerca Traslazionale sul Melanoma, Divisione di Oncologia Medica del Melanoma, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy. · San Martino Hospital, National Institute for Cancer Research, Genoa, Italy. · University Hospital Pisa, "Gathered Hospitals of Santa Chiara", Pisa, Italy. · Department of Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 24100024
2013
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale," Naples, Italy. · Pubmed 22874771
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy. · Pubmed 23460532
  • Istituto Nazionale Tumori, Fondazione "G, Pascale", Naples, Italy. · Pubmed 23731854
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 22551296
2011
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 21439082
2010
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • aDepartment of Medical Oncology, Royal North Shore Hospital bDepartment of Medical Oncology Melanoma Institute Australia cDepartment of Medical Oncology, The University of Sydney, Sydney, New South Wales, Australia dDepartment of Medical Oncology, Istituto Nazionale Tumori 'Fondazione Pascale', Naples, Campania, Italy. · Pubmed 28230715
2015
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Unit of Melanoma, Immunotherapy and Innovative Therapies, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24114495
  • Pathology Unit, Istituto Nazionale Tumori Fondazione, "G. Pascale", via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24993904
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • National Cancer Institute-Fondazione Pascale, Naples, Italy. · Pubmed 23036080
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Department Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 23317446
2012
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy. · Pubmed 22433222
  • Department of Surgery, National Cancer Institute, Via Mariano Semmola, Naples, Italy. · Pubmed 22800396
  • Pathology Unit, Istituto Nazionale Tumori Fondazione G, Pascale, via Mariano Semmola, 80131, Naples, Italy. · Pubmed 22583695
2011
  • Division of Cardiology, National Cancer Institute, Sen. Pascale Foundation, via Mariano Semmola, 80131 Naples, Italy. · Pubmed 21705351
Harvard University
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
National Institutes of Health
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Universita degli Studi di Siena
2018
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
National Cancer Institute Milan
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2015
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
2015
  • Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 25952781
Unspecified
2017
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
2016
  • General Dermatology and Oncology Service, Ambroise-Paré Hospital, AP-HP, University of Versailles-Saint-Quentin-en-Yvelines, Boulogne, France · Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · National Institute for Tumors Foundation 'G. Pascale', Napoli. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Dermatology and Skin Cancers, La Timone APHM Hospital, Aix-Marseille University, Marseille, France. · Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland. · Dermatology Clinic, Hôtel-Dieu Hospital, CHU Nantes, Nantes, France. · Department of Surgical Oncology, UTMD Anderson Cancer Center, Houston. · Moffitt Cancer Center, Tampa, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Center and Institute of Oncology, Warsaw, Poland. · Melanoma and Soft Tissue Sarcoma Division, European Institute of Oncology, Milan, Italy. · Petrov Research Institute of Oncology, St Petersburg, Russian Federation. · Department of Dermatology, University of Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Hospital of Brest, Brest, France. · GSK Vaccines, Rixensart, Belgium. · Pubmed 27502712
  • Oncology of Melanoma Unit, European Institute of Oncology, Milan. · Medical Oncology and Immunotherapy, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples. · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Istituto Toscano Tumori, University Hospital of Siena, Siena. · IV Oncology Division, Istituto Dermopatico dell'Immacolata IRCCS, Rome. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Department of Medical Oncology, National Institute for Cancer Research, IRCCS San Martino, Genoa. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan · Pubmed 26802161
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France · Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland · Jeremy Marsden, University Hospital Birmingham, Birmingham · Philippa Corrie, Addenbrookes Hospital, Cambridge · Poulam M. Patel, University of Nottingham, Nottingham · Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom · Mario Santinami, Istituto Nazionale dei Tumori, Milan · Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli · Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence · Maria Grazia Bernengo, University Hospital Turin, Turin, Italy · Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway · Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands · Lars Bastholt, Odense University Hospital, Odense, Denmark · and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
2015
2013
  • Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Tuscan Cancer Institute, Siena. · Pubmed 24067719
Miscellaneous cities in Italy
2017
  • Institute of Genetics and Biophysics (IGB), A. Buzzati-Traverso, CNR, I-80131 Naples, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, I-80131 Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, CNR, I-07100 Sassari, Italy. · Unit of Pathology, Hospital-University Health Unit (AOU), I-07100 Sassari, Italy. · Department of Biomedical and Biotechnological Sciences-BIOMETEC, University of Catania, I-95100 Catania, Italy. · Pubmed 29048639
2012
  • Istituto Chimica Biomolecolare, Consiglio Nazionaledelle Ricerche, Italy. · Pubmed 22614978
European Institute of Oncology
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2015
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
Hospital Universitario La Paz
2015
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
2015
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
Institut Gustave Roussy
2015
  • 1Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori-Fondazione G. Pascale, Naples, Italy; 2Odense University Hospital, Odense, Denmark; 3Newcastle University, Newcastle, Australia; 4Instituto de Oncologia Angel Rolfo, Buenos Aires, Argentina; 5Institut Gustave Roussy, Villejuif, France; 6University of Kiel, Kiel, Germany; 7Hospital La Paz, Madrid, Spain; and 8Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
2015
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
Miscellaneous institutions in Naples, IT
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy · David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco · Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles · Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA · Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville · Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris · Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France · Dirk Schadendorf, University Hospital Essen, Essen · Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany · Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • National Tumor Institute, Foundation G Pascale, Naples, Italy. · Pubmed 23414587
2010
  • Unit of Medical Oncology and Innovative Therapy, National Tumor Institute, Naples, Italy. · Pubmed 20406483
  • Unit of Medical Oncology and Innovative Therapy and Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 20712892
2008
  • Unit of Medical Oncology and Innovative Therapy, Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 18954464
2014
  • Istituto Nazionale Tunori Fondazione 'G. Pascale', Naples, Italy. · Pubmed 24419498
2013
  • Department of Melanoma, Sarcoma and Skin Cancer, Via Mariano Semmola, Naples 80131, Italy. · Pubmed 23379355
2012
  • Unit of Medical Oncology and Innovative Therapy, G Pascale Institute of National Tumor Foundation, Naples, Italy. · Pubmed 22993335
  • Institute of Tumors of Naples, Naples, Italy. · Pubmed 22752507
2010
22 Other Locations Show
Yearly article counts 53023232225164552
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.